Overweight or obese women who have less-than-optimal levels of vitamin D and lose more than 15% of their body weight experience significant increases in circulating levels of this fat-soluble nutrient, according to a study released last week by researchers at Fred Hutchinson Cancer Research Center.
Costco Wholesale EVP, CFO and director Richard Galanti told investors during the company’s third quarter 2011 earnings call last week that average prices in pharmacy probably would decline due to the introduction of generic versions of branded drugs.
In a major win for its pharmacy benefit management business, CVS Caremark will handle the $3 billion mail-order and specialty prescription drug benefit for the Federal Employee Program starting January 2012, which, for the last three years, had been handled by rival Medco Health Solutions.
The House of Representatives last week passed the FY2012 Defense Authorization bill by a vote of 322 to 96. The bill includes a small increase in the Tricare Prime fee, the American Society of Military Comptrollers noted in a statement, but caps future increases at no more than the cost-of-living adjustment.
INGfertility on Tuesday announced its Pre-Seed "fertility-friendly" personal lubricant will be available in all Walgreens pharmacies as of Wednesday, following Facebook demand for increased distribution.
New results from a late-stage clinical trial of a Sanofi drug for Type 2 diabetes indicated that the drug can reduce blood sugar in patients without increasing the risk of causing the blood sugar levels to dip too low, the French drug maker said Tuesday.
The major consumer press is beginning to understand the value of community pharmacy and the importance of medication adherence in managing outcomes in healthcare spending, as evidenced by the recent USA Today article "Studies: Missed meds could cost more than $250B a year."
CVS Caremark and a panel of health experts explored research findings and the problem of medication nonadherence Thursday morning during CVS Caremark’s first-ever national forum on medication nonadherence at the National Press Club in Washington, D.C.
Drug maker Johnson & Johnson plans to file for regulatory approval for 11 new drugs between 2011 and 2015, the company said Thursday in relation to a meeting between J&J’s executive committee and investors.